CORRECTION
| The first 100% of the full text of this article appears below. |
In the article on page 19 of the February issue (D W Gilley. Cholinesterase inhibitors reduce burden and care time for informal carers of people with Alzheimer’s disease. Evid Based Ment Health 2006;9:19) there was an error in the notes section. The meta-analysis did not include NMDA receptor agonists, although the narrative review did. The unapproved drugs velnacrine and metrifonate are classified as acetylcholinesterase inhibitors (ChEIs), not NMDA receptor agonists. As ChEIs, these drugs were included in the meta-analysis. Please refer to the original article (Linger JH, Martire LM, Schulz R. Caregiver specific outcomes in antidementia clinical drug trials: a systematic review and meta-analysis. J Am Geriatr Soc 2005;53:983–90.) for appropriate phrasing as to the limitation posed by the inclusion of these agents.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
Services
- Email this link to a friend
- Similar articles in this journal
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
